Climb Bio Inc
NASDAQ:CLYM
Climb Bio Inc
NASDAQ:CLYM
Price:
6.56
USD
-5.61%
Market Closed
Market Cap:
$313.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Climb Bio Inc
NASDAQ:CLYM
|
US |
|
F
|
Fortescue Ltd
XMUN:FVJ
|
AU |
|
W
|
Washington Real Estate Investment Trust
F:WRI
|
US |
|
G
|
Green Minerals AS
OSE:GEM
|
NO |
|
Larsen and Toubro Ltd
F:LTO
|
IN |
|
B
|
Bear Creek Mining Corp
XTSX:BCM
|
CA |
|
E
|
Ege Gubre Sanayii AS
IST:EGGUB.E
|
TR |
|
N
|
Navamedic ASA
OSE:NAVA
|
NO |
|
I
|
Immuneering Corp
NASDAQ:IMRX
|
US |
Wall Street
Price Targets
CLYM Price Targets Summary
Climb Bio Inc
Climb Bio Inc
Wall Street analysts forecast CLYM stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
CLYM
is 15.67 USD
with a low forecast of 8.08 USD and a high forecast of 27.3 USD.
Lowest
Price Target
8.08
USD
23% Upside
Average
Price Target
15.67
USD
139% Upside
Highest
Price Target
27.3
USD
316% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CLYM's stock price target?
Price Target
15.67
USD
15.67
USD
According to Wall Street analysts, the average 1-year price target for
CLYM
is 15.67 USD
with a low forecast of 8.08 USD and a high forecast of 27.3 USD.
